, Tracking Stock Market Picks
Enter Symbol:
Baxter International Inc. (BAX) [hlAlert]

up 9.03 %

Baxter International Inc. (BAX) rated Outperform with price target $70 by RBC Capital Mkts

Posted on: Tuesday,  Dec 18, 2012  10:25 AM ET by RBC Capital Mkts

RBC Capital Mkts rated Outperform Baxter International Inc. (NYSE: BAX) on 12/18/2012, when the stock price was $66.62. Since then, Baxter International
Inc. has gained 9.04% of its value until RBC Capital Mkts rated BAX Sector Perform on 01/08/2015, when the price was $72.64.
If you would have followed this RBC Capital Mkts's recommendation on BAX, you would have gained 9.03% of your investment in 751 days.

Baxter engages in the worldwide development, manufacture and distribution of a diversified line of products, systems and services used primarily in the health-care field. The company's products are used by hospitals, clinical and medical research laboratories, blood and dialysis centers, rehabilitation centers, nursing homes, doctors' offices and by patients, at home, under physician supervision.

RBC Capital Markets is an international corporate and investment bank that provides innovative solutions and a focused set of products and services to institutions, corporations, governments and high net worth clients around the world. With nearly 3,700 professional and support staff, we operate out of 75 offices in 15 countries and deliver our products and services through operations in Asia and Australasia, the UK and Europe and in every major North American city.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/8/2015 9:25 AM Hold
72.64 76.00
as of 12/31/2012
1 Week down  -0.46 %
1 Month up  0.58 %
3 Months up  10.60 %
1 YTD up  34.72 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/18/2012 10:25 AM Buy
66.62 70.00
6/22/2012 9:25 AM Buy
51.77 58.00
2/15/2012 10:25 AM Buy
56.64 62.00
4/25/2011 9:25 AM Buy
56.25 59.00
2/26/2009 8:25 AM Buy

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy